Historical data shows that a consistent $500 monthly investment into Artelo Biosciences, Inc. (ARTL) starting in 2020 would have turned a total investment of $49K into $5K today. This represents a total return of -90.3% over the 6-year period, compounding through dividend reinvestment and market growth.
The Impact of Dividend Reinvestment (DRIP)
Artelo Biosciences, Inc. does not currently pay a notable dividend. For growth-focused stocks like ARTL, dollar cost averaging relies entirely on price appreciation. Over the 6-year period, the strategy successfully captured the stock's price movements, resulting in a final portfolio value of $5K without the need for dividend reinvestment.
ARTL vs. S&P 500 (SPY) Benchmark
When comparing this dollar cost averaging strategy against a broad market index,ARTL underperformed the S&P 500 ETF (SPY). The same $500 monthly contributions into SPY would have grown to $86K, compared to ARTL's $5K.